Mast cell stabilizers: from pathogenic roles to targeting therapies
Authors:
Open Access
- 1 August 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1418897
Abstract
Mast cells (MCs) are bone-marrow-derived haematopoietic cells that are widely distributed in human tissues. When activated, they will release tryptase, histamine and other mediators that play major roles in a diverse array of diseases/disorders, including allergies, inflammation, cardiovascular diseases, autoimmune diseases, cancers and even death. The multiple pathological effects of MCs have made their stabilizers a research hotspot for the treatment of related diseases. To date, the clinically available MC stabilizers are limited. Considering the rapidly increasing incidence rate and widespread prevalence of MC-related diseases, a comprehensive reference is needed for the clinicians or researchers to identify and choose efficacious MC stabilizers. This review analyzes the mechanism of MC activation, and summarizes the progress made so far in the development of MC stabilizers. MC stabilizers are classified by the action mechanism here, including acting on cell surface receptors, disturbing signal transduction pathways and interfering exocytosis systems. Particular emphasis is placed on the clinical applications and the future development direction of MC stabilizers.Keywords
This publication has 146 references indexed in Scilit:
- A Phosphatase‐Mimetic Nano‐Stabilizer of Mast Cells for Long‐Term Prevention of Allergic DiseaseAdvanced Science, 2021
- Mast Cell-Specific MRGPRX2: a Key Modulator of Neuro-Immune Interaction in Allergic DiseasesCurrent Allergy and Asthma Reports, 2021
- Ligands and Signaling of Mas-Related G Protein-Coupled Receptor-X2 in Mast Cell Activation2020
- Thymoquinone Inhibits Neurogenic Inflammation Underlying Migraine Through Modulation of Calcitonin Gene-Related Peptide Release and Stabilization of Meningeal Mast Cells in Glyceryltrinitrate-Induced Migraine Model in RatsInflammation, 2019
- Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitisCochrane Database of Systematic Reviews, 2015
- The mast cell stabilizer ketotifen reduces joint capsule fibrosis in a rabbit model of post-traumatic joint contracturesInflammation Research, 2011
- CD300a is expressed on human basophils and seems to inhibit IgE/FcεRI‐dependent anaphylactic degranulationCytometry Part B: Clinical Cytometry, 2011
- Effect of statins on lipoprotein receptor expression in cell lines from human mast cells and basophilsEuropean Journal of Clinical Pharmacology, 2003
- Two mast cell stabilizers, pemirolast potassium 0.1% and nedocromil sodium 2%, in the treatment of seasonal allergic conjunctivitis: a comparative study.Advances in Therapy, 2003
- The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthmaInflammation Research, 1986